Acquired Immunodeficiency Syndrome-Related Malignancies in the Era of Highly Active Antiretroviral Therapy
- 1 July 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in International Journal of Hematology
- Vol. 84 (1), 3-11
- https://doi.org/10.1532/ijh97.06088
Abstract
Since the beginning of the acquired immunodeficiency syndrome (AIDS) epidemic, malignancies have been an important feature of this disease. Several cancers, including Kaposi sarcoma (KS), certain aggressive B-cell lymphomas, and cervical can-cer, are considered AIDS-defining when they occur in patients infected with human immunodeficiency virus. Most AIDS defining tumors are associated with one of 3 DNA viruses: KS-associated herpesvirus, Epstein-Barr virus, or human papillo mavirus. With the introduction of highly active antiretroviral therapy (HAART), the incidence of KS and certain lymphomashas decreased, whereas that of other tumors, such as cervical cancer, has undergone little change. Several new drugs and therapies have been developed for KS and AIDS-related lymphomas, and these treatments, plus the development of HAART, have contributed to improvements in morbidity and mortality.At the same time, the improved overall survival of patients with HAART has contributed to an increase in the number of patients living with AIDS in developed countries such as the United States. With the development of HAART and improved prevention and treatment of opportunistic infections, an increasing percentage of the deaths in AIDS patients have been from malignancies. Strategies for prevention, screening, and therapy remain important areas of research in this developing field.Keywords
This publication has 73 references indexed in Scilit:
- Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcomaBlood, 2006
- Incidence of Cervical Squamous Intraepithelial Lesions Associated With HIV Serostatus, CD4 Cell Counts, and Human Papillomavirus Test ResultsJama-Journal Of The American Medical Association, 2005
- Highly Active Antiretroviral Therapy in AIDS-Associated Kaposi's Sarcoma: Implications for the Design of Therapeutic Trials in Patients With Advanced, Symptomatic Kaposi's SarcomaJournal of Clinical Oncology, 2004
- Incidence of Non–AIDS-Defining Cancers Before and During the Highly Active Antiretroviral Therapy Era in a Cohort of Human Immunodeficiency Virus–Infected PatientsJournal of Clinical Oncology, 2003
- Pathogenesis and manifestations of human herpesvirus-8-associated disordersSeminars in Hematology, 2003
- A Pilot Study of Cidofovir in Patients with Kaposi SarcomaThe Journal of Infectious Diseases, 2003
- Human Interferon-γ–inducible Protein 10 (IP-10) Inhibits Constitutive Signaling of Kaposi's Sarcoma–associated Herpesvirus G Protein–coupled ReceptorThe Journal of Experimental Medicine, 1998
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- Preliminary Observations on the Effect of Recombinant Leukocyte a Interferon in Homosexual Men with Kaposi's SarcomaNew England Journal of Medicine, 1983
- OUTBREAK OF BURKITT'S-LIKE LYMPHOMA IN HOMOSEXUAL MENThe Lancet, 1982